Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic

Res Social Adm Pharm. 2021 Jan;17(1):2053. doi: 10.1016/j.sapharm.2020.03.020. Epub 2020 Mar 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / prevention & control*
  • Cannabidiol / administration & dosage
  • Cannabidiol / adverse effects*
  • Communication
  • Deception*
  • Humans
  • Pharmacists / organization & administration
  • Professional Role
  • SARS-CoV-2 / isolation & purification

Substances

  • Cannabidiol